Skip to main content
Premium Trial:

Request an Annual Quote

Bristol-Myers Licenses Ingenuity s Pathway Software

NEW YORK, July 26 (GenomeWeb News) - Bristol-Myers Squibb has taken a multi-year license to Ingenuity's Pathways Analysis and Pathways Knowledge Base applications, Ingenuity said today.


Under the agreement, Ingenuity Pathways Analysis will be available to all BMS scientists. Both Ingenuity products will be integrated with existing bioinformatics solutions at the drug company.


Ingenuity's Pathways Knowledge Base is a curated database of modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases. The Pathways Analysis application analyzes these relationships.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.